Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Fresenius SE & Co. KGaA (OTCMKTS:FSNUYGet Rating) have earned an average recommendation of “Hold” from the twelve analysts that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, five have given a hold recommendation and six have given a buy recommendation to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $50.55.

FSNUY has been the subject of a number of research analyst reports. Berenberg Bank upped their price objective on shares of Fresenius SE & Co. KGaA from €55.95 ($60.16) to €60.25 ($64.78) and gave the company a “buy” rating in a research report on Wednesday, February 16th. Deutsche Bank Aktiengesellschaft cut their price objective on shares of Fresenius SE & Co. KGaA from €38.00 ($40.86) to €36.00 ($38.71) and set a “hold” rating for the company in a research report on Friday, February 25th. JPMorgan Chase & Co. cut their price objective on shares of Fresenius SE & Co. KGaA from €42.30 ($45.48) to €34.50 ($37.10) and set a “neutral” rating for the company in a research report on Thursday, February 24th. Zacks Investment Research lowered shares of Fresenius SE & Co. KGaA from a “hold” rating to a “sell” rating in a research report on Friday, February 4th. Finally, Credit Suisse Group cut their price objective on shares of Fresenius SE & Co. KGaA from €43.00 ($46.24) to €35.00 ($37.63) and set a “neutral” rating for the company in a research report on Monday, February 28th.

Shares of FSNUY opened at $9.41 on Wednesday. The company has a 50-day simple moving average of $9.14 and a 200-day simple moving average of $10.09. The firm has a market capitalization of $21.02 billion, a P/E ratio of 9.70 and a beta of 1.31. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.85 and a current ratio of 1.13. Fresenius SE & Co. KGaA has a 52 week low of $7.37 and a 52 week high of $14.81.

About Fresenius SE & Co. KGaA (Get Rating)

Fresenius SE & Co KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.

See Also

Analyst Recommendations for Fresenius SE & Co. KGaA (OTCMKTS:FSNUY)

Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.